EYPT EyePoint, Inc.

NASDAQ
$3.62

EyePoint, Inc. (EYPT) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is a loss of $0.81 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -69.5% since its last earnings release on August 5, 2026.

EyePoint Missed Consensus Estimates
Wednesday, August 5, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 7:00 AM ET
Earnings Whisper
-
vs ($0.81)
Rev est $200K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $5.47

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About EyePoint, Inc.

EyePoint Pharmaceuticals, Inc. is a pharmaceutical company committed to developing and commercializing innovative therapeutics to help improve the lives of patients with serious eye disorders.

Sector

Healthcare

Industry

Biotechnology

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.